The Defense Advanced Research Projects Agency has awarded GE Healthcare a grant worth $9.6 million to lead the research and development of a device that takes just under an hour to detect infectious diseases on-site using a nasal swab. The pocket-size device initially is being targeted for use in diagnosing methicillin-resistant Staphylococcus aureus, or MRSA.

Related Summaries